Skip to main content
    I

    In8bio Inc (INAB)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.82
    -0.00 (-0.49%)

    Market Cap: $8.86M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    In8bio Inc (INAB) Earnings: Report Dates and Results

    Updated Nov 5, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    In8bio (INAB) is expected to report earnings on Mar 10, 2027. In the quarter ended Sep 30, 2026, In8bio reported EPS of -$0.24, above the -$0.57 estimate. It beat the EPS estimate in 6 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    48%(11/23)
    Avg Surprise
    +3.52%
    Streak
    6 Q

    Upcoming Estimates

    Reports Mar 10, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.36
    Range-$0.64 - -$0.18
    5 analysts
    Revenue Consensus
    N/A
    RangeN/A
    5 analysts
    Reports May 5, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.33
    Range-$0.33 - -$0.33
    1 analysts
    EPS Revisions
    1
    0
    30d
    EPS Estimate DriftChange to current
    90d ago$0.00n/a
    60d ago-$0.39+15.4%
    30d ago-$0.39+15.4%
    7d ago-$0.39+15.4%
    Current-$0.33
    Revenue Consensus
    N/A
    RangeN/A
    1 analysts

    Next Report

    INAB has an expected report date of Mar 10, 2027.

    Earnings History

    Of the 23 quarters below that had an estimate, INAB beat 11, missed 9 and matched 3. The widest gap in the table came in the quarter ended Mar 31, 2026, when EPS landed 62.32% above the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReported
    Sep 30, 2026-$0.24-$0.57-$0.57 - -$0.22+57.89%BeatN/A31 up, 0 downNov 5, 2026
    Jun 30, 2026-$0.25-$0.61-$0.61 - -$0.24+59.02%BeatN/A30 up, 0 downAug 6, 2026
    Mar 31, 2026-$0.26-$0.69-$0.79 - -$0.59+62.32%BeatN/A20 up, 0 downMay 7, 2026
    Dec 31, 2025-$0.45-$0.48-$0.77 - -$0.18+5.26%BeatN/A20 up, 0 downMar 12, 2026
    Sep 30, 2025-$0.85-$1.25-$1.28 - -$1.21+32.00%BeatN/A22 up, 0 downNov 6, 2025
    Jun 30, 2025-$1.24-$1.50-$2.10 - -$1.50+17.33%BeatN/A31 up, 0 downAug 7, 2025
    Mar 31, 2025-$2.10-$2.00-$2.10 - -$1.80-5.00%MissN/A31 up, 0 downMay 7, 2025
    Dec 31, 2024-$0.08-$0.07-$0.10 - -$0.07-14.29%MissN/A42 up, 0 downMar 13, 2025
    Sep 30, 2024-$4.50-$4.72-$5.41 - -$4.20+4.66%BeatN/A20 up, 0 downNov 12, 2024
    Jun 30, 2024-$5.70-$5.04-$6.31 - -$4.50-13.10%MissN/A50 up, 0 downAug 8, 2024
    Mar 31, 2024-$6.00-$5.18-$6.01 - -$4.50-15.83%MissN/A40 up, 0 downMay 9, 2024
    Dec 31, 2023-$0.21-$0.15-$0.17 - -$0.13-40.00%MissN/A30 up, 0 downMar 14, 2024
    Sep 30, 2023-$6.90-$7.35-$7.51 - -$7.21+6.12%BeatN/A20 up, 0 downNov 9, 2023
    Jun 30, 2023-$8.10-$8.10-$8.41 - -$7.510.00%In lineN/A30 up, 0 downAug 10, 2023
    Mar 31, 2023-$9.00-$9.60-$9.91 - -$8.11+6.25%BeatN/A32 up, 0 downMay 12, 2023
    Dec 31, 2022-$0.37-$0.32-$0.35 - -$0.28-15.63%MissN/A30 up, 0 downMar 30, 2023
    Sep 30, 2022-$10.20-$8.10-$10.21 - -$7.81-25.93%MissN/A30 up, 0 downNov 10, 2022
    Jun 30, 2022-$11.40-$8.70-$9.91 - -$7.51-31.03%MissN/A20 up, 0 downAug 12, 2022
    Mar 31, 2022-$9.90-$9.90-$10.21 - -$9.610.00%In lineN/A20 up, 0 downMay 12, 2022
    Dec 31, 2021-$0.21-$0.26-$0.32 - -$0.21+19.23%BeatN/A20 up, 0 downMar 17, 2022
    Sep 30, 2021-$7.50-$8.25-$15.32 - -$6.01+9.09%BeatN/A20 up, 0 downNov 10, 2021
    Jun 30, 2021-$0.55-$0.40N/A-37.50%MissN/AN/AN/AJul 30, 2021
    Mar 31, 2021-$0.82-$0.82N/A0.00%In lineN/AN/AN/AJun 2, 2021
    Dec 31, 2020-$0.82N/AN/AN/AN/AN/AN/AN/AMar 31, 2021
    Sep 30, 2020-$0.30N/AN/AN/AN/AN/AN/AN/ANov 5, 2020
    Jun 30, 2020-$0.69N/AN/AN/AN/AN/AN/AN/ASep 30, 2020
    Dec 31, 2019-$0.59N/AN/AN/AN/AN/AN/AN/AMar 30, 2020
    Sep 30, 2019-$0.48N/AN/AN/AN/AN/AN/AN/ADec 31, 2019
    Jun 30, 2019-$0.48N/AN/AN/AN/AN/AN/AN/ASep 30, 2019
    Mar 31, 2019-$0.16N/AN/AN/AN/AN/AN/AN/AJun 29, 2019
    Dec 31, 2018-$0.16N/AN/AN/AN/AN/AN/AN/AMar 30, 2019
    Last 31 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$4.64, after -$16.28 the year before. It was -$0.16 for the year ended Dec 31, 2018, the oldest of the 8 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$4.64N/A
    Dec 31, 2024-$16.28N/A
    Dec 31, 2023-$24.21N/A
    Dec 31, 2022-$31.87N/A
    Dec 31, 2021-$9.08N/A
    Dec 31, 2020-$1.81N/A
    Dec 31, 2019-$1.71N/A
    Dec 31, 2018-$0.16N/A

    Frequently Asked Questions About INAB

    When is In8bio's next earnings date?

    In8bio's next earnings report is expected for Mar 10, 2027.

    Did INAB beat earnings estimates last quarter?

    Yes. In8bio reported EPS of -$0.24 for the quarter ended Sep 30, 2026, above the -$0.57 estimate, a 57.89% surprise.

    What EPS do analysts expect from INAB next quarter?

    The consensus EPS estimate for In8bio for the quarter ending Dec 31, 2026 is -$0.36 from 5 analysts, with estimates from -$0.64 to -$0.18.

    How often does INAB beat earnings estimates?

    In8bio beat the EPS estimate in 6 of the last 8 quarters, with an average surprise of +26.82%.